Release Date: 25/09/23 08:49 Summary: Allkem confirms material growth profile underpinned by 40 Mt Price Sensitive: Yes Download Document 863.1KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%